InsidersTradesSigma
Discover the full directors' dealings record of 진원생명과학, a publicly traded company based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Healthcare sector, 진원생명과학 has published 12 public disclosures. Market capitalisation: €95.3bn. The latest transaction was disclosed on 29 April 2026 (Other). Among the most active insiders: 박영근. All data is accessible without an account.
FY ended December 2025 · cache
0 of 0 declarations